ICU Medical Inc. is a leading medical device company that specializes in the development and manufacturing of innovative products for intravenous therapy, infusion systems, and related applications
The company focuses on enhancing patient safety and improving clinical outcomes through its advanced technologies, including smart infusion systems and closed-loop medication delivery solutions. With a commitment to quality and reliability, ICU Medical serves a wide range of healthcare settings, helping to streamline hospital operations and enhance the overall patient experience. Their extensive portfolio also encompasses vital components used in various healthcare environments, underscoring their role as a crucial player in the medical technology sector.
Smiths Medical, a subsidiary of ICU Medical, recalls Bivona neonatal, pediatric, and adult tracheostomy tubes due to a defect that may lead to serious injury or death following the FDA's classification of the issue as a serious health risk.
Companies Reporting Before The Bell • Kosmos Energy (NYSEKOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
The market looks set to extend last week’s gains, with the stock futures holding up early Monday ahead of a slew of earnings reports mostly from the small and mid-cap space.
Gainers PaxMedica, Inc. (NASDAQPXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.
Gainers Nuburu, Inc. (NYSEBURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser technology.
Stifel raised the price target for XPO, Inc. (NYSEXPO) from $48 to $51. Stifel analyst J. Bruce Chan downgraded the stock from Buy to Hold. XPO shares fell 1.5% to $47.72 in pre-market trading.
